Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Family Medicine
Clinical Trials: Macular Edema
A listing of clinical trials currently looking for volunteers to enroll in Macular Edema studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Mesa : Barnet Dulaney Perkins Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Phoenix : Barnet Dulaney Perkins Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Phoenix : Retina Consultants of Arizona
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
California
Bakersfield : California Retina Consultants
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
Beverly Hills : Retina-Vitreous Associates
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Beverly Hills :
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Huntington Beach : South Coast Retina
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Long Beach : South Coast Retina
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
View More »
Los Angeles : Jules Stein Eye Institute
Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
Marietta : Marietta Eye Clinic
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Sacramento : Retinal Consultants Medical Group, Inc.
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Santa Barbara : California Retina Consultants
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
Santa Maria : California Retina Consultants
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
Santa Monica : Thomas Hanscom AMC
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Torrance : Retina Macula Institute
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
Torrance : South Coast Retina
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Torrance : Retina Macula Institute
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Florida
Clearwater : Retina Vitreous Associates of Florida
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Fort Lauderdale : Retina Group of Florida
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Lakeland : Central Florida Retina Institute
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Miami : Bascom Palmer Eye Insitute
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Palm Beach Gardens : Bascom Palmer of the Palm Beaches
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
View More »
St. Petersburg : Retina Vitreous Associates of Florida
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Winter Haven : Center for Retina and Macular Disease
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Winter Haven :
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Indiana
Indianapolis : Thomas A. Cuilla, MD, PC at Midwest Eye Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Iowa
Cedar Rapids : Iowa Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Iowa City : University of Iowa Department of Ophthalmology and Visual Sciences
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Marshalltown : Wolfe Eye Clinic
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Kentucky
Lexington : University of Kentucky Chandler Medical Center
Eye Conditions: Eye Research Study on Macular Edema Due to Retinal Vein Blockage.
View More »
Lexington : University of Kentucky Department of Ophthalmology
Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
Paducah : Paducah Retinal Center
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Maryland
Baltimore : Wilmer Eye Institute, Johns Hopkins University
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
Baltimore : Elman Retina Group, P.A.
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Baltimore : Johns Hopkins Unversity
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Baltimore :
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Baltimore : Johns Hopkins University
SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
View More »
Hagerstown : Cumberland Valley Retina Center
Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
Massachusetts
Boston :
Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
Boston :
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Boston : Ophthalmic Consultants of Boston
Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
Missouri
Chesterfield : St. Lukes Hospital
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
St. Louis : Barnes Jewish Hospital
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
St. Louis : St. Louis Eye Surgery and Laser Center
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
St. Louis : Washington University School of Medicine
Intravitreal Aflibercept Injection for Radiation Retinopathy
New Hampshire
Portsmouth : Eyesight Ophthalmic Services, PA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
New Jersey
Toms River : Retina Vitreous Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
New York
New York : Retina Specialists PC
Ozurdex for Macular Edema Post Membrane Peeling
North Carolina
Charlotte : Southeast Clinical Research Associates, LLC
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Charlotte :
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Ohio
Cincinnati :
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Cleveland : Cole Eye Institute
Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
Pennsylvania
West Mifflin : Associates in Ophthalmology
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
South Carolina
Columbia : Palmetto Retina Center
Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
South Dakota
Rapid City : Black Hills Regioinal Eye Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Texas
Arlington :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Harlingen : Valley Retina Institute
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Houston : Retina Consultants of Houston
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Houston : Robert Cizik Eye Clinic - University of Texas Houston
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Houston : Retina Consultants of Houston
Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)
View More »
Houston : Retinal Consultants of Houston
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
McAllen : Valley Retina Institute
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
McAllen : Valley Retina Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
San Antonio : Retinal Consultants of San Antonio
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Argentina
Buenos Aires : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Rosario : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Australia
Adelaide : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Brisbane : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
East Melbourne : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Fitzroy : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Forster : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
View More »
Hobart : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Kogarah : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
North Adelaide : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Parramatta : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
South Launceston : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Strathfield : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Sydney : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Westmead : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Belgium
Bonheiden : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Hasselt : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Leuven : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Canada
Calgary : Calgary Retina Consultants
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Drummondville : Clinique ChirurgiVision
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Halifax : Victoria General Hospital, Department of Ophthalmology
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
London : Ivey Eye Institute
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
London Ontario : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
View More »
Miramichi : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Mississauga : Canadian Centre for Advanced Eye Therapeutics
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Montreal : Hôpital Notre Dame (CHUM)
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Montreal : Hôpital Maisonneuve-Rosemont
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Montreal : Royal Victoria Hospital
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Ottawa : The Ottawa Hospital - General Campus
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Quebec : Institut de l'oeil des Laurentides
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Québec : Centre Oculaire de Québec
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Saskatoon : Saskatoon City Hospital / Spadina Clinic
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Sherbrooke : Dr.Michel Giunta Clinique Médicale
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
St-John's : Memorial University Health Sciences Centre / Bense Eye Centre
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
St-John's : Memorial University Health Sciences Centre / Newfoundland Drive Medical Clinic
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Toronto : Sunnybrook Health Sciences Centre
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Toronto : Toronto Western Hospital
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Toronto : St-Michael's Hospital - Dept of Ophthalmology
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Vancouver : UBC - Eye Care Center
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Victoria : Novartis Investigative Site
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
Victoria : Retina Consultants of Victoria
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
China
Beijing :
Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)
Denmark
Copenhagen :
Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
Glostrup : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
France
Paris :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Paris :
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
Germany
Ahaus :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Augsburg : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Bad Rothenfelde : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Berlin :
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
Berlin : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
View More »
Berlin : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Berlin : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Bonn : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Bonn : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Bonn : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Bremen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Bremen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Chemnitz : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Chemnitz : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Chemnitz : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Darmstadt : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Darmstadt : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Darmstadt : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Dortmund : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Dortmund : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Dresden : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Dresden : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Dresden : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Duesseldorf : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Düsseldorf : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Düsseldorf : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Düsseldorf : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Essen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Essen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Frankfurt : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Freiburg : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Freiburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Freiburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Freiburg i. Br : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Glauchau : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Göttingen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Göttingen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Göttingen : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Hagen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Hagen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Halle : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Hamburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Hamburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Hamburg : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Ingolstadt : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Karlsruhe : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Karlsruhe : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Karlsruhe : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Kiel : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Kiel : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Koeln : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Koeln : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Köln : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Köln : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Leipzig : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Leipzig : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Leipzig : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Leipzig : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Lüdenscheid : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Lüdenscheid : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Ludwigshafen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Ludwigshafen : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Marburg : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Muelheim : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Muenster : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Muenster : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Mühlheim : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Mühlheim : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
München : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Munich : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Munich :
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
Münster : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Münster : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Nürnberg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Nürnberg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Postdam : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Postdam : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Recklinghausen : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Regensburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Regensburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Regensburg : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Siegburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Siegburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Sulzbach : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Tübingen : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Ulm :
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Ulm : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Ulm : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Ulm : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Ulm : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Wolfsburg : Novartis Investigative Site
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Würzburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Würzburg : Novartis Investigative Site
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Israel
Jerusalem : Hadassah Ein Kerem Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Petah Tiqva : Rabin Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Rehovot : Kaplan Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Tel Aviv : Tel Aviv Sourasky Medical Center
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema
Tel Aviv : Tel Aviv Sourasky Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
View More »
Tel Aviv :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Tel Aviv :
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
Zerifin : Assaf Harofe Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Italy
Milan :
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
Milano : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Japan
Osaka : Santen study sites
Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)
Osaka : Santen study sites
Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
Korea, Republic of
Seoul : Santen study sites
Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
Netherlands
Rotterdam : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Tilburg : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Norway
Bodo : Novartis Investigative site
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Oslo :
Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
Oslo : Novartis Investigative Site
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Trondheim : Novartis Investigative site
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Poland
Bielsko-Biala : Novartis Investigative Site
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion
Portugal
Coimbra :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Singapore
Singapore : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Spain
Barcelona :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Madrid :
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
Sweden
Uppsala :
Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
United Kingdom
Ayr : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Birmingham : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Bolton : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Bradford :
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Cardiff : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
View More »
Colchester : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
County Durham : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Devon : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Dunfermline : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Essex : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Hull : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Liverpool : Novartis Investigational Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
London : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
London :
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
London :
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
London : Moorfields Eye Hospital NHSFT Research and Treatment Centre
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
Manchester : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Norfolk : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Norfolk : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Rugby : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Sheffield : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Stoke on Trent : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Surrey : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Uxbridge : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
York : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment